Acuta Capital Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-661,565
| Closed | -$7.11M | – | 50 |
|
|
2021
Q1 | $7.11M | Sell |
661,565
-141,435
| -18% | -$1.52M | 2.56% | 18 |
|
|
2020
Q4 | $11.8M | Sell |
803,000
-50,000
| -6% | -$735K | 3.21% | 10 |
|
|
2020
Q3 | $12.1M | Buy |
+853,000
| New | +$12.1M | 3.29% | 9 |
|
|
2015
Q1 | – | Sell |
-19,000
| Closed | -$171K | – | 66 |
|
|
2014
Q4 | $171K | Buy |
+19,000
| New | +$171K | 0.12% | 52 |
|